Zoeken
Solide tumoren, HER2-mutatie/amplificatie, fase 1 populatie, zongertinib
Solide tumoren, HER2 positief, fase 1, click-cleavable beeldvorming
Solide tumoren, fase 1 populatie, patritumab deruxtecan
Solide tumoren, fase 1, infinatamab deruxtexan
Solide tumoren, fase 1, MK-3120 (ADC met anti-nectine-4 en topoisomerase-I-remmer)
Solide tumoren, fase 1, T-cell engager, anti-nectine-4
Solide tumoren, dMMR-MSI-H, fase 1, WRN inhibitor +/- dostarlimab
Solide tumoren, EMA geregistreerde middelen
Solide tumoren, ‘actionable’ moleculaire target
Formulier
Endometriumcarcinoom
Gynaecologische tumoren
